S

trong data science is critical to getting a better understanding of clinical trial results — and perhaps no one understands that better than the Food and Drug Administration.

So the agency’s Oncology Center for Excellence has harnessed computer modeling tools to help make better sense of clinical data — so as to help guide companies into developing better clinical trials. It’s a collaborative effort, with FDA working with academia and other government agencies to help make sense of the jumbles of data that are presented to FDA.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.